Drug intelligence / Profile preview

Podoven

Development stage
Unknown
Lead developer
Epitech
Modality
Small Molecules
Administration
Topical
01

Overview

Podoven is a topical formulation developed by Epitech specifically for podological applications, including the management of foot vascular and venous conditions. The product utilizes ALIAmide (Autacoid Local Inflammation Antagonism) technology, primarily through the active ingredient **adelmidrol**, a synthetic analogue of the endogenous fatty acid amide palmitoylethanolamide (PEA). Podoven is designed to modulate mast cell hyper-reactivity and dermo-epidermal inflammation, which are often implicated in the symptoms of chronic venous insufficiency and other foot-related skin disorders. By acting as a PPAR-alpha agonist and stabilizing mast cells, the formulation helps to alleviate local edema, itching, and skin reactivity in the lower limbs.

Brand names
Podoven
Other names
PODOVEN
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on Podoven.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Podoven.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call